Evotec Inks Screening Pact with Active Biotech | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Evotec said today that it will use its high-throughput compound screening and assay development technologies to identify small molecule modulators for a target selected by Stockholm-based Active Biotech.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.